Compare DG & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DG | TEVA |
|---|---|---|
| Founded | 1939 | 1901 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.4B | 30.2B |
| IPO Year | N/A | N/A |
| Metric | DG | TEVA |
|---|---|---|
| Price | $132.78 | $29.74 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 23 | 9 |
| Target Price | ★ $127.00 | $29.78 |
| AVG Volume (30 Days) | 4.3M | ★ 10.4M |
| Earning Date | 12-04-2025 | 01-28-2026 |
| Dividend Yield | ★ 1.77% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.79 | 0.62 |
| Revenue | ★ $42,117,664,000.00 | $16,776,000,000.00 |
| Revenue This Year | $7.83 | $4.74 |
| Revenue Next Year | $4.16 | $0.48 |
| P/E Ratio | ★ $23.00 | $48.90 |
| Revenue Growth | ★ 4.86 | 0.02 |
| 52 Week Low | $66.43 | $12.47 |
| 52 Week High | $135.08 | $30.20 |
| Indicator | DG | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 75.15 | 79.52 |
| Support Level | $123.86 | $28.00 |
| Resistance Level | $135.08 | $30.20 |
| Average True Range (ATR) | 4.81 | 0.65 |
| MACD | 2.32 | 0.18 |
| Stochastic Oscillator | 93.62 | 92.58 |
With more than 20,000 locations, Dollar General's banner is nearly ubiquitous across the rural United States. Dollar General serves as a convenient shopping destination for fill-in store trips, with its value proposition most relevant to consumers in small communities with a dearth of shopping options. The retailer operates a frugal store of about 7,500 square feet and primarily offers an assortment of branded and private-label consumable items (80% of net sales) such as paper and cleaning products, packaged food, and health and beauty items at low prices. Dollar General also offers a limited assortment of seasonal merchandise, home products, and apparel. The firm sells most items at a price point of $10 or less.
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.